Franz H Messerli

Director of the Hypertension Program

Division of Cardiology, St. Luke’s-Roosevelt Hospital Corporation, New York

Articles

The Role of Dihydropyridine Calcium Channel Blockers in the Treatment of Hypertension and Cardiovascular Disease - An Update

Franz H Messerli, Georg Noll, Lars H Lindholm, et al

Citation: European Cardiovascular Disease 2006;2(1):16–20

The Role of Dihydropyridine Calcium Channel Blockers in the Treatment of Hypertension and Cardiovascular Disease - An Update

Franz H Messerli, Georg Noll, Lars H Lindholm, et al

Citation: European Cardiovascular Disease 2006;2(1):1–6